Partner Nate Lacktman was quoted in a Healthcare Informatics article, “Healthcare Leaders Praise Telehealth Advancements, Delayed E&M Coding Changes in Recent CMS Rule,” about the Centers for Medicare & Medicaid Services’ (CMS) decision to begin reimbursing health care providers for certain virtual care visits with patients.
Reimbursing providers for virtual check-ins, Lacktman said, exemplifies CMS’ renewed vision and desire to bring the Medicare program into the future of clinically-valid virtual care services, though he noted that the virtual check-in has to be conducted by the physician or a qualified health care professional, not office staff. He also said patient consent to use telehealth is required each time the provider connects with the patient.
“Providers frustrated with the labyrinthine and narrow Medicare coverage of telehealth services can take comfort in the fact that virtual check-ins are not considered a Medicare telehealth service,” he said.
Reimbursing providers for virtual check-ins, Lacktman said, exemplifies CMS’ renewed vision and desire to bring the Medicare program into the future of clinically-valid virtual care services, though he noted that the virtual check-in has to be conducted by the physician or a qualified health care professional, not office staff. He also said patient consent to use telehealth is required each time the provider connects with the patient.
“Providers frustrated with the labyrinthine and narrow Medicare coverage of telehealth services can take comfort in the fact that virtual check-ins are not considered a Medicare telehealth service,” he said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”